OTLK logo

OUTLOOK THERAPEUTICS INC

OTLKNASDAQ
πŸ† #2785 by market capUS Equity
$133.77β–² $10.70 (+8.00%)
Simulated price
1hβ€”
24hβ–² 8.0%
7dβ–² 12824.6%
14dβ–² 13079.3%
30dβ–² 8475.0%
1yβ–² 6362.3%
🏦Market Cap
$215M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
512.0x
Expensive
Otter Score
65
Fair

Trading Snapshot

Day Range
$132.84 – $136.42
52-Week Range
$0.16 – $3.39
Volume
$2.81B
Avg Volume
$2.04B
Shares Outstanding
187.0M
Next Earnings
Oct 17, 2026

Fundamentals Snapshot

Annual Revenue
$420,000
Last Q Revenue
$107,321
P/E Ratio
β€”
P/S Ratio
512.0x
EPS (TTM)
$-1.26
Dividend Yield
β€”

Why Investors Own OTLK

  • βœ“High-growth profile β€” revenue up +29.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 57% gross margin and 15% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$420,000β–² +23.9% YoY
Gross Margin (TTM)
57.1%β–² +0.6% YoY
Operating Income (TTM)
$156,240β–² +23.9% YoY
Free Cash Flow (TTM)
$61,740β–² +23.9% YoY

About OUTLOOK THERAPEUTICS INC

A company profile for OUTLOOK THERAPEUTICS INC isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
65/100

Analyst Price Target

β“˜
Average Target
$172.08
β–² +28.6% Upside
High Target$195.97
Low Target$147.33
Based on 36 analysts

Latest News & Updates